Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III)

Condition:   Typhoid Interventions:   Biological: Vi-DT (Multi-dose formulation);   Biological: Vi-DT (Single dose formulation);   Biological: Control Vaccine Sponsors:   International Vaccine Institute;   SK Bioscience Co., Ltd.;   Bill and Melinda Gates Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials